Theralase Technologies Inc.

    Jurisdiction
    Canada
    ISIN
    CA88337V1004 (TLT.V)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer, bacteria, and viruses in Canada, the United States, and internationally. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €652.47K
    Gross margin
    55.8%
    EBIT
    -€2.07M
    EBIT margin
    -317.3%
    Net income
    -€2.61M
    Net margin
    -400.7%

    Statement period: - (published )

    Dividends

    Last dividend amount
    CA$0.41
    Ex date

    Earnings Calls

    Latest earnings call: June 9, 2025

    Add to watchlist

    Notifications